We have extensive M&A experience, gained across continents and cultures, that we call upon to assist our clients achieve favourable business outcomes. We advise on deal structuring, acquisitions, divestments, joint ventures, and PE/VC investments.

​

Our prior industry experience as in-house counsel informs our approach to M&A. Our lawyers have negotiated and handled strategic pharmaceutical acquisitions worth over USD 5 Billion, including acquisitions, minority investments, joint ventures and dispositions. Our M&A experience spans every continent except Antartica. Our industry focus gives us an edge in pharmaceutical M&A, when it comes to diligence, structuring and negotiations.